Evidence map›Paper›PMID 32820081›Full record

ArticleThorax2020

Molecular epidemiology and clinical impact of rhinovirus infections in adults during three epidemic seasons in 11 European countries (2007-2010).

Kalina T Zlateva, Anneloes L van Rijn, Peter Simmonds, Frank E J Coenjaerts, Anton M van Loon, Theo J M Verheij, Jutte J C de Vries, Paul Little, Christopher C Butler, Erik W van Zwet and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Thorax, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The rhinovirus puzzle: Linking virus and host factors to childhood asthma.The Journal of allergy and clinical immunology · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Kalina T Zlateva *Medical Microbiology, Leiden Universitair Medisch Centrum, Leiden, The Netherlands.
Anneloes L van Rijn *Medical Microbiology, Leiden Universitair Medisch Centrum, Leiden, The Netherlands.ORCID 0000-0002-0551-5543
Peter SimmondsInfection and Immunity Division, University of Edinburgh, Edinburgh, UK.
Frank E J CoenjaertsDepartment of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Anton M van LoonDepartment of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Theo J M VerheijDepartment of Data Management, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Jutte J C de VriesMedical Microbiology, Leiden Universitair Medisch Centrum, Leiden, The Netherlands.
Paul LittlePrimary Care and Population Science, University of Southampton, Southampton, UK.ORCID 0000-0003-3664-1873
Christopher C ButlerNuffield Department of Primary Care Sciences, Oxford University, Oxford, UK.
Erik W van ZwetDepartment of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands.
Herman GoossensDepartment of Medical Microbiology, Vaccine & Infectious Diseases Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Margareta IevenDepartment of Medical Microbiology, Vaccine & Infectious Diseases Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Eric C J ClaasMedical Microbiology, Leiden Universitair Medisch Centrum, Leiden, The Netherlands E.C.J.Claas@lumc.nl.
GRACE Study Group
Leiden University Medical Center · NLUniversity Medical Center Utrecht · NLUniversity of Antwerp · BECentre for Immunity, Infection and Evolution · GBUniversity of Oxford · GBUniversity of Southampton · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDifferences in clinical impact between rhinovirus (RVs) species and types in adults are not well established. The objective of this study was to determine the epidemiology and clinical impact of the different RV species.

methodsWe conducted a prospective study of RVs infections in adults with acute cough/lower respiratory tract infection (LRTI) and asymptomatic controls. Subjects were recruited from 16 primary care networks located in 11 European countries between 2007 and 2010. RV detection and genotyping was performed by means of real time and conventional reverse-transcriptase polymerase chain reaction assays, followed by sequence analysis. Clinical data were obtained from medical records and patient symptom diaries.

resultsRVs were detected in 566 (19%) of 3016 symptomatic adults, 102 (4%) of their 2539 follow-up samples and 67 (4%) of 1677 asymptomatic controls. Genotyping was successful for 538 (95%) symptomatic subjects, 86 (84%) follow-up infections and 62 (93%) controls. RV-A was the prevailing species, associated with an increased risk of LRTI as compared with RV-B (relative risk (RR), 4.5; 95% CI 2.5 to 7.9; p<0.001) and RV-C (RR 2.2; 95% CI 1.2 to 3.9; p=0.010). In symptomatic subjects, RV-A loads were higher than those of RV-B (p=0.015). Symptom scores and duration were similar across species. More RV-A infected patients felt generally unwell in comparison to RV-C (p=0·023). Of the 140 RV types identified, five were new types; asymptomatic infections were associated with multiple types.

interpretationIn adults, RV-A is significantly more often detected in cases with acute cough/LRTI than RV-C, while RV-B infection is often found in asymptomatic patients.

Indexed as

EpidemicsSeasonsAdultEuropeFemaleHumansMaleMiddle AgedMolecular EpidemiologyPicornaviridae InfectionsProspective StudiesRespiratory Tract InfectionsRhinovirusrespiratory Infectionviral infection

Identifiers

PMID32820081
PMCPMC7509388
OpenAlexW3074567945

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.